Dirk Thye
CIK 1638945 · CEO and CMO · last filed 2026-01-23
Dirk Thye is a CEO and CMO who has filed 13 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for QNCX, was dated Jan 23, 2026. Across all open-market trades the lifetime net is +$317.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $928.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$928.9K
3
13
$317.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QNCX | CEO and CMO | 994,885 | $0.93 | $928.9K | $317.5K | 10 | 2026-01-23 |
| Quince Therapeutics, Inc. (CRTX) Delisted | Chief Executive Officer | 280,911 | $1.95 | $547.8K | $0 | 2 | 2022-05-27 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Chief Medical Officer | — | $221.38 | — | $0 | 1 | 2016-03-18 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-23 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2025-12-12 | QNCX | Gift (G) | — | $0 | EDGAR |
| 2025-06-23 | QNCX | Grant (A) | +150,944 | $181.1K | EDGAR |
| 2025-02-11 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2024-09-03 | QNCX | Buy (P) | +154,500 | $107.4K | EDGAR |
| 2024-02-02 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2024-01-17 | QNCX | Exer (M) | +240,530 | $190.8K | EDGAR |
| 2023-08-11 | QNCX | Buy (P) | +88,000 | $110.9K | EDGAR |
| 2023-08-09 | QNCX | Buy (P) | +80,000 | $99.2K | EDGAR |
| 2023-02-02 | QNCX | Grant (A) | — | $0 | EDGAR |